ZJYL
Jin Medical International Ltd.
NASDAQ · Healthcare · Medical - Instruments & Supplies · CN
$2.08
−3.26%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 42.6M | 20.7M | 23.5M | 19.8M | 19.2M |
| Cost of Revenue | 28.2M | 14.6M | 14.0M | 13.0M | 13.0M |
| Gross Profit | 14.4M | 6.0M | 9.5M | 6.8M | 6.2M |
| Operating Expenses | |||||
| R&D Expense | 3.3M | 1.6M | 1.5M | 1.5M | 1.9M |
| SG&A Expense | 8.5M | 3.9M | 4.4M | 2.4M | 2.2M |
| General & Admin Expense | 3.2M | 2.5M | 3.3M | 1.9M | 1.8M |
| Selling & Marketing Expense | 1.5M | 1.3M | 1.1M | 453.3K | 402.0K |
| Other Expenses | 176.6K | — | — | — | — |
| Total Operating Expenses | 12.0M | 5.4M | 5.9M | 3.9M | 4.1M |
| Cost and Expenses | 40.2M | 20.1M | 19.9M | 17.0M | 17.1M |
| Operating Income (EBIT) | 2.4M | 608.2K | 3.6M | 2.9M | 2.1M |
| Non-Operating | |||||
| Interest Income | 1.1M | 789.1K | 466.5K | 182.7K | 181.6K |
| Interest Expense | 215.1K | — | — | — | — |
| Net Interest Income | 913.9K | 789.1K | 466.5K | 182.7K | 181.6K |
| Other Non-Op Income/Expense | 1.1M | 987.6K | 545.0K | 354.7K | 612.1K |
| Non-Operating Income (excl Interest) | — | — | — | (354.7K) | (612.1K) |
| EBT (Pre-Tax Income) | 3.5M | 1.6M | 4.2M | 3.2M | 2.7M |
| Income Tax Expense | 573.4K | 214.6K | 763.9K | 343.7K | 36.1K |
| Bottom Line | |||||
| Net Income | 3.0M | 1.2M | 3.7M | 2.9M | 2.7M |
| Earnings from Cont. Ops | 2.9M | 1.4M | 3.4M | 2.9M | 2.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 3.0M | 1.2M | 3.7M | 2.9M | 2.7M |
| Per Share | |||||
| Basic EPS | $0.37 | $0.15 | $0.47 | $0.40 | $0.40 |
| Diluted EPS | $0.37 | $0.15 | $0.47 | $0.40 | $0.40 |
| Revenue Per Share | $5.44 | $2.64 | $3.00 | $2.73 | $2.84 |
| Shares | |||||
| Basic Shares Outstanding | 7.8M | 7.8M | 7.8M | 7.3M | 6.8M |
| Diluted Shares Outstanding | 7.8M | 7.8M | 7.8M | 7.3M | 6.8M |
| Profitability Metrics | |||||
| EBITDA | 2.9M | 932.9K | 4.0M | 3.1M | 3.1M |
| D&A | 548.1K | 324.7K | 346.1K | 225.9K | 357.3K |
| EBIT | 2.4M | 608.2K | 3.6M | 2.9M | 2.7M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026